About OSSFILA Technology
OSSFILA Technology is a Healthcare company based in Kowloon (China) founded in 2018 by Justin Suen, Andrew Li, Karen Hoi Lam Kwan, and Daphne Tam. It operates as a provider of bioactive filament and 3D printed materials for medical applications. It operates in the Healthcare and Technology sectors. Its chief executive is Justin Suen. Its focus areas include High Tech, 3D Printing, Applications and Orthopedics. Its competitors include Otto Bock, OssDsign, Proteor, 4WEB Medical and K2M and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
OSS FILA Technology was founded in 2018 in Kowloon, China, focusing on the medical sector through 3D printing innovations. Bioactive filaments, standardized implants, and patient-specific implants are developed and provided for medical use. Traceability is measured using specialized technology. Commercial products feature hydroxyapatite-coated copolymer nanoparticles in filament form, supporting implant applications in healthcare operations.
- Headquarters Kowloon, China
- Founders Justin Suen, Andrew Li, Karen Hoi Lam Kwan, Daphne Tam
- SectorsHealthcareTechnology
- Website ossfila.com/en
- Social LinkedIn
- Investors
Funding Insights of OSSFILA Technology
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of OSSFILA Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in OSSFILA Technology
OSSFILA Technology has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include K-Startup Grand Challenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sector-agnostic acceleration is provided to startups through global programs. | – | k-startupgc.org | Seongnam-si, South Korea |
Investor details for OSSFILA Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OSSFILA Technology
4 people are tracked at OSSFILA Technology (4 in leadership).
| Name | Role | Group |
|---|---|---|
Justin Suen | Co-Founder & CEO | Leadership |
Andrew Li | Co-Founder | Leadership |
Karen Hoi Lam Kwan | Co-Founder | Leadership |
Daphne Tam | Co-Founder | Leadership |
Complete people profiles for OSSFILA Technology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OSSFILA Technology
2 dated milestones of OSSFILA Technology across 4 years, from founding to its latest funding, stage changes and deals.
- Founded OSSFILA Technology is founded.
- Funding First funding round.
Competitors of OSSFILA Technology
OSSFILA Technology has 9 listed competitors in our database, 8 of them funded. They include Otto Bock, OssDsign, Proteor, 4WEB Medical and K2M, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ottobock.com | 1919 | Duderstadt, Germany | $17M | 238 | Prosthetic and orthotic devices are developed for individuals with disabilities. | |
| ossdsign.com | 2011 | Uppsala, Sweden | $19.75M | – | Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma | |
| proteor.com | 1913 | Dijon, France | – | – | Prostheses and orthoses devices are developed for orthopedic supports. | |
| 4webmedical.com | 2008 | Frisco, United States | $12.5M | – | 3D printed spinal implants | |
| k2m.com | 2004 | Leesburg, United States | $21.5M | 426 | Devices for complex spinal disorders are developed using advanced technologies. | |
| nanochon.com | 2016 | Burke, United States | $6M | – | 3D-printed implants are developed for treating joint injuries. | |
| fourierintelligence.com | 2015 | Singapore | $82.94M | – | Rehabilitation robotics development and redefining services are provided. | |
| hroboticsinc.com | 2018 | – | $10M | 11 | Robotic rehabilitation systems are developed for remote patient treatment. | |
| conformis.com | 2004 | Billerica, United States | $446.75M | 242 | 3D-printed orthopedic products are developed for customized knee implants. |
Detailed competitors of OSSFILA Technology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of OSSFILA Technology
Websites that share an audience with OSSFILA Technology (ossfila.com).
Websites whose visitors overlap most with OSSFILA Technology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| novusls.com | 100% | 6.6K | #3,166,478 | View details |
Top companies in Orthopedics
10 companies that operate in the same segment as OSSFILA Technology (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | 4,125 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OSSFILA Technology
OSSFILA Technology was founded in 2018 and raised its 1st funding round 4 years after it was founded.
OSSFILA Technology is headquartered in Kowloon, China. It is registered at Kowloon, Hong Kong, China.
Justin Suen is the current CEO of OSSFILA Technology. They have also founded this company.
OSS FILA Technology was founded in 2018 in Kowloon, China, focusing on the medical sector through 3D printing innovations. Bioactive filaments, standardized implants, and patient-specific implants are developed and provided for medical use. Traceability is measured using specialized technology. Commercial products feature hydroxyapatite-coated copolymer nanoparticles in filament form, supporting implant applications in healthcare operations.
OSSFILA Technology's top competitors include Otto Bock, OssDsign and 4WEB Medical.
OSSFILA Technology has 1 investor. Key investors include K-Startup Grand Challenge.